Key result
False-positive STEMI accounts for ~8% of suspected cases but carries mortality similar to true STEMI.
Why the study?
Little is known about patient- and system-related factors associated with false-positive STEMI diagnoses among patients presenting with suspected STEMI.
What are the incidence, correlates, and clinical outcomes of false-positive STEMI activations compared to true STEMI?
Cohort (n=827)
What are the incidence, correlates, and clinical outcomes of false-positive STEMI activations compared to true STEMI?
False-positive STEMI activations occur in about 8% of suspected cases and, despite the absence of coronary disease, are associated with similar 30-day and 1-year mortality as true STEMI.
Comparable mortality in false-positive STEMI warrants clinical vigilance; extends observations but remains hypothesis-generating.
BACKGROUND: A subgroup of patients presenting with suspected ST-elevation myocardial infarction (STEMI) have no culprit lesion during coronary angiography (false-positive STEMI). Little is known about patient- and system-related factors that are associated with false-positive STEMI. We evaluated the incidence, correlates, delay, final diagnosis, and outcome of patients with false-positive STEMI. METHODS: We studied 827 consecutive patients presenting with suspected STEMI between January 2011-September 2012. RESULTS: A false positive STEMI activation was identified in 68 patients (8.2%). Patients with false-positive STEMI were younger (57 vs 63 year; p=0.020), less often had hypercholesterolemia (19 vs 43%; p=0.001), and had a higher heart rate (82 vs 75 bpm; p=0.014). The association between these factors and false-positive STEMI activation persisted in multivariate analysis. The duration of symptoms to call was longer in false-positive STEMI patients (128 vs 83 min; p=0.030), although this did not reach statistical significance in multivariate analysis. Final diagnosis in patients with false-positive STEMI activation was particularly from unknown origin (41%). There were no significant differences in mortality at 30 days and one year between patients with STEMI and false-positive STEMI. CONCLUSION: The incidence of false-positive STEMI was 8.2% in patients suspected of STEMI. Patients with false-positive STEMI differ from STEMI patients in certain baseline characteristics and in patient delay. Interestingly, absence of coronary disease did not translate into better clinical outcome.
No takes yet. Share an insight, caveat, or question.
Groot et al. (2015) conducted a cohort in Suspected ST-elevation myocardial infarction (STEMI) (n=827). False-positive STEMI vs. True STEMI was evaluated on Mortality at 30 days and one year. False-positive STEMI occurred in 8.2% of suspected STEMI cases; these patients were younger (57 vs 63 years) but had similar 30-day and 1-year mortality compared to true STEMI patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: